Phi Pharma SA

Swiss Biotech Association

Not a member
Claim / update listing

Phi Pharma SA is developing a new class of anti-cancer drugs: peptide drug conjugates effective in multiple human cancers using an innovative mechanism of cell entry: novel sugar-based drug targets.

https://www.phi-pharma.com/

Location

Place du Midi 36, 1950 Sion, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2012
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

LATAM Pharma Innovative Ventures AG

LATAM Pharma offers made-to-measure solutions of immunization to public and private markets in Latin American and Caribbean countries.
6300 Zug

Member

Onward Therapeutics SA

We are a development stage oncology company, focusing on the identification of innovative technologies and the development of truly breakthrough medicines for the treatment of cancer.
1066 Épalinges

Member

NovaGo Therapeutics

NovaGo is focused on human antibody therapeutics targeting blood vessel & nerve growth. Our proprietary antibodies target Nogo-A, one of the most potent vascular & nerve growth inhibitors & have the potential to be a safe & effective treatment in ophthalmology and central nervous system indications.
8952 Schlieren

Member